Lupin Earns Great Place To Work® India 2026 Nation Builders Recognition

Date:

Share post:

Lupin Limited (Lupin)  announced that it has been recognized among India’s Best Employers in the Nation-Builders Category 2026 by Great Place To Work® India, ranking among the Top 14 organizations nationwide. This prestigious honor highlightsLupin’s commitment to building a purpose-driven workplace culture while expanding global healthcare access and driving community development.

The Nation-Builders category recognizes organizations whose impact extends far beyond exceptional business performance, celebrating significant contributions to national employment, comprehensive people development, and societal advancement. Selection is based on an independent, rigorous assessment including the Trust Index™ employee experience survey and a deep Culture Audit™ evaluating everyday people practices.

“We are honored by this recognition, which celebrates the culture our people bring to life every day,” said YashwantMahadik, President – Global Human Resources, Lupin. “At Lupin, we are focused on creating an environment where individuals feel supported, empowered, and connected to a shared purpose. By investing in our people, we enable meaningful contributions to patients and society.”

Headquartered in Mumbai, Lupin operates 15 state-of-the-art manufacturing sites and 7 research centers globally, supported by over 26,000 professionals.

Written by: Pragna Biswas

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...